TABR Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Sell
1,429
-4
-0.3% -$4.09K 1.46% 13
2026
Q1
$1.32M Buy
1,433
+4
+0.3% +$4.05K 1.21% 13
2025
Q4
$1.54M Buy
1,429
+2
+0.1% +$1.91K 1.02% 14
2025
Q3
$1.04M Hold
1,427
0.71% 16
2025
Q2
$1.11M Buy
1,427
+1
+0.1% +$777 0.95% 13
2025
Q1
$1.18M Buy
1,426
+1
+0.1% +$832 1.23% 15
2024
Q4
$1.1M Buy
+1,425
New +$1.18M 0.96% 15

Other funds holding LLY

TABR Capital Management's LLY Position: Q2 2026 in Review

TABR Capital Management reduced its Eli Lilly (LLY) stake by 0.28% in Q2 2026, selling an estimated $4.09K and leaving 1,429 shares worth $1.71M. The position accounts for 1.46% of the portfolio, ranked #13.

TABR Capital Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,857 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TABR Capital Management held 1,429 shares of Eli Lilly worth $1.71M as of Q2 2026.
  • TABR Capital Management sold 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 1.46% of TABR Capital Management's portfolio in Q2 2026, its #13 holding.
  • TABR Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,857 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TABR Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.